Q: A company called Rocket Doctor was talked about on market call the other day. Is it worth than investing in?
5i Research Answer:
AIDR is quite small at $75M market cap, after a 57% gain this year. It provides healthcare software solutions. Essentially, an AI doctor. But, currently it has minimal revenue, losses and negative cash flow. No analyst coverage. It does have some partnerships with insurance companies, with large numbers of members, so there is some potential here. But we need to see some sales in order to gauge what future profitability might be. There is competition in the space, certainly, as well. Insiders own 3%. While interesting, we would consider it too early here.